102 related articles for article (PubMed ID: 15501962)
1. Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients.
Lindholm E; Daneryd P; Körner U; Hyltander A; Fouladiun M; Lundholm K
Clin Cancer Res; 2004 Oct; 10(20):6855-64. PubMed ID: 15501962
[TBL] [Abstract][Full Text] [Related]
2. Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.
Daneryd P; Svanberg E; Körner U; Lindholm E; Sandström R; Brevinge H; Pettersson C; Bosaeus I; Lundholm K
Cancer Res; 1998 Dec; 58(23):5374-9. PubMed ID: 9850068
[TBL] [Abstract][Full Text] [Related]
3. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.
Lundholm K; Körner U; Gunnebo L; Sixt-Ammilon P; Fouladiun M; Daneryd P; Bosaeus I
Clin Cancer Res; 2007 May; 13(9):2699-706. PubMed ID: 17473202
[TBL] [Abstract][Full Text] [Related]
4. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.
Lundholm K; Daneryd P; Bosaeus I; Körner U; Lindholm E
Cancer; 2004 May; 100(9):1967-77. PubMed ID: 15112279
[TBL] [Abstract][Full Text] [Related]
5. Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia.
Fouladiun M; Körner U; Gunnebo L; Sixt-Ammilon P; Bosaeus I; Lundholm K
Clin Cancer Res; 2007 Nov; 13(21):6379-85. PubMed ID: 17975150
[TBL] [Abstract][Full Text] [Related]
6. Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy.
Dahele M; Skipworth RJ; Wall L; Voss A; Preston T; Fearon KC
J Pain Symptom Manage; 2007 Jun; 33(6):676-85. PubMed ID: 17360150
[TBL] [Abstract][Full Text] [Related]
7. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
8. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
Desai J; Demetri GD
Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
[TBL] [Abstract][Full Text] [Related]
12. The development of an evidence-based physical self-management rehabilitation programme for cancer survivors.
van Weert E; Hoekstra-Weebers JE; May AM; Korstjens I; Ros WJ; van der Schans CP
Patient Educ Couns; 2008 May; 71(2):169-90. PubMed ID: 18255249
[TBL] [Abstract][Full Text] [Related]
13. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.
Jensen K; Bonde Jensen A; Grau C
Radiother Oncol; 2006 Mar; 78(3):298-305. PubMed ID: 16524633
[TBL] [Abstract][Full Text] [Related]
14. [Exhaustion and fatigue--a neglected problem in hematologic oncology].
Zahner J; Meran J; Karthaus M
Wien Med Wochenschr; 2001; 151(3-4):89-93. PubMed ID: 11789424
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.
Gramignano G; Lusso MR; Madeddu C; Massa E; Serpe R; Deiana L; Lamonica G; Dessì M; Spiga C; Astara G; Macciò A; Mantovani G
Nutrition; 2006 Feb; 22(2):136-45. PubMed ID: 16459226
[TBL] [Abstract][Full Text] [Related]
16. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care.
MacDonald N
J Support Oncol; 2007 Apr; 5(4):157-62; discussion 164-6, 183. PubMed ID: 17500503
[TBL] [Abstract][Full Text] [Related]
17. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
[TBL] [Abstract][Full Text] [Related]
18. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
19. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
